Ordenar

Buscar

01/12/2025 Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy
Torrent, A, Morgades, M, Iacoboni, G, Reguera, JL, Kwon, M, Corral, LL, Hernani, R, Ortiz-Maldonado, V, Sanz, J, Gonzalez, ACC, Guerra, L, Pina, JMS, Mussetti, A, Garcia-Sancho, AM, Bastos-Oreiro, M, Delgado, J, Carpio, C, Sancho, JM, Perez-Martinez, A, Barba, P. Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy. BONE MARROW TRANSPLANTATION. 2025; 60(12)DOI:10.1038/s41409-025-02722-y. PMID:41028300. IF:5.200(Q1/1D).
01/12/2025 Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol
Casares, LD, Pereiro, JE, Fernández, MTT, García, XC, Millet, JP, Solchaga, VP, Elorza, EN, García, JT, de Santiago, AD, Márquez, RL, Gallardo, JFM, Galán, VG, Alonso, MM, Brusola, AG, Rey, RR, García, LA, Herrero, FS, Serrano, RG, Fullola, MG, Díez, MT, Zanon, TT, Portero, MF, García, PA, Lopez, AMS, Aznar, ML, Camprecios, JM, Saborit, N, Montalvá, AS. Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Bmj Open Respiratory Research. 2025; 12(1)DOI:10.1136/bmjresp-2024-002475. PMID:41360613. IF:3.400(Q2/3D).
01/12/2025 Re: Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia
Mendoza, M, Garcia-Manau, P, Bonacina, E, Maiz, N. Re: Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2025; 66(6)DOI:10.1002/uog.70021. PMID:40878378. IF:6.300(Q1/1D).
01/12/2025 Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality
Canelo-Aybar, C, Alonso-Coello, P, Muratov, S, Tarride, JE, Dimitrova, N, Giusti, F, Borisch, B, Castells, X, Duffy, SW, Fitzpatrick, P, Follmann, M, Giordano, L, Hofvind, S, Lebeau, A, Quinn, C, Torresin, A, Rossi, PG, Schünemann, H, Nyström, L, Broeders, M. Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality. BREAST. 2025; 84DOI:10.1016/j.breast.2025.104621. PMID:41202390. IF:7.900(Q1/1D).
29/11/2025 Mapping of Determinants of Urinary Sex Steroid Metabolites During Late Pregnancy: Results from Two Spanish Cohorts
Laveriano-Santos, EP, Renard-Dausset, E, Bustamante, M, Pelegri, D, García-Ruiz, Z, Ruiz-Rivera, M, Cosin-Tomas, M, Llurba-Olive, E, Gomez-Roig, MD, Haro, N, Pozo, OJ, Dadvand, P, Vrijheid, M, Maitre, L. Mapping of Determinants of Urinary Sex Steroid Metabolites During Late Pregnancy: Results from Two Spanish Cohorts. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(23)DOI:10.3390/ijms262311598. PMID:41373750. IF:4.900(Q1/3D).
28/11/2025 Somatic reversion in CD137 deficiency correlating with Epstein-Barr virus control and clinical improvement
Batlle-Maso, L, Pulido, JP, Esteve-Codina, A, Perurena-Prieto, J, Franco-Jarava, C, Aguilo-Cucurull, A, Martínez-Gallo, M, Cea, C, Rodriguez-Aliberas, M, Soler-Palacín, P, Casals, F, Velao, SR, Torrent, M, Alsina, L, Colobran, R. Somatic reversion in CD137 deficiency correlating with Epstein-Barr virus control and clinical improvement. npj Genomic Medicine. 2025; 10(1)DOI:10.1038/s41525-025-00535-y. PMID:41315311. IF:4.800(Q1/2D).
28/11/2025 Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
Langtry, A, Rabadan, R, Alonso, L, Filip, I, Sabroso-Lasa, S, Moreno-Oya, A, Lawlor, R, Carrato, A, Alvarez-Gallego, R, Iglesias, M, Molero, X, Löhr, MJ, Michalski, CW, Perea, J, O'Rorke, M, Barberà, VM, Tardon, A, Farré, A, Muñoz-Bellvís, L, Crnogorac-Jurcevic, T, Domínguez-Muñoz, E, Gress, TM, Greenhalf, W, Sharp, L, Balsells, J, Costello, E, Kleeff, J, Kong, B, Mora, J, O'Driscoll, D, Scarpa, A, Ye, WM, Real, FX, de Maturana, EL, Malats, N, Gomez-Rubio, P, Molina-Montes, E, Márquez, M, Milne, R, Alfaro, A, Lobato, T, Estudillo, L, Beghelli, S, Cubillo, A, Hidalgo, M, Peinado, P, Salas, I, Pascual, JR, Earl, J, Caminoa, A, Guillén-Ponce, C, Rodríguez-Garrote, M, Longo-Muñoz, F, Ferreiro, R, Pachon, V, Vaz, MA, Muñoz, M, Ilzarbe, L, Alvarez-Urturi, C, Bessa, X, Bory, F, Márquez, L, Poves, I, Burdío, F, Grande, L, Gimeno, J, Guarner, L, Balcells, J, Salcedo, M, Merino, X, Esposito, I, Mota, C, Huang, JQ, Verbeke, C, Yu, JR, Loinaz, C, Rodríguez-Peralto, JL, Teijo, A, Peláez, P, Martín, M, Artigas, V, Guarner, C, Sancho, FJ, Concepcion, M, Cajal, TRY, Szafranska, J, Murray, L, Cantwell, M, Gallego, J, Barneo, L, Rodriguez-Suarez, M, Pazos, Y, Lozano, A, Luaces, M, Blanco-Antona, F, Manzano, JMS, Troncoso, MLG, de Matos, AO, Buchholz, M, Neesse, A, Kocher, HM, Bhattacharya, S, Abraham, AT, Ennis, D, Dowe, T, Radon, T. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65811-y. PMID:41315260. IF:15.700(Q1/1D).
28/11/2025 Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Muñoz-Vendrell, A, Campoy-Díaz, S, Valín-Villanueva, P, Casas-Limón, J, Fernández-Lázaro, I, González-García, N, Santos-Lasaosa, S, Osorio, YG, Gonzalez-Martinez, A, Campdelacreu, J, Portocarrero-Sánchez, L, Sánchez, LMC, Sánchez, SMG, Pérez-de-la-parte, A, Sánchez-Mateos, NM, López-Bravo, A, Mínguez-Olaondo, A, Sánchez-Soblechero, A, Ros, AL, Hernández, CM, López, AA, Layos-Romero, A, Caronna, E, Torres-Ferrús, M, Alpuente, A, Pozo-Rosich, P, Belvís, R, Garcia-Azorin, D, Díaz-de-Terán, J, Guerrero-Peral, AL, Gago-Veiga, AB, Huerta-Villanueva, M. Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response. JOURNAL OF HEADACHE AND PAIN. 2025; 27(1)DOI:10.1186/s10194-025-02239-1. PMID:41315923. IF:7.900(Q1/1D).